If you are a type 2 diabetic who has taken Januvia for your diabetes and subsequently developed pancreatic cancer, you are not alone as a Januvia Pancreatic Cancer Victim. You may be entitled to financial compensation through a Januvia lawsuit for pancreatic cancer victims. A Januvia lawsuit claims that the manufacturers of Januvia knew or should have known about the potential for Januvia to result in pancreatic cancer.
Those who are diagnosed as pancreatic cancer victims face an especially trying road ahead. Pancreatic cancer is responsible for the fourth most cancer deaths in the United States. Pancreatic cancer can be especially dangerous because it is often difficult to diagnose and in many cases, pancreatic cancer is not diagnosed until later stages in which the most effective treatment options may not work as well.
Januvia (generic: sitagliptin) is part of a class of diabetes drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. Januvia was approved by the Food and Drug Administration (FDA) in 2006 for the treatment of adults suffering from type 2 diabetes. Merck and Co manufacturers Januvia.
A study conducted by researchers at UCLA and subsequently published in a journal called Diabetes, discovered that Januvia was associated with the incidence of certain abnormalities in the pancreas that are believed to be increased risk factors of pancreatitis. Medical experts list pancreatitis as one of the most common risk factors to the development of pancreatic cancer.
After its appeal in 2006 until 2009, the Food and Drug Administration (FDA) received more than 88 adverse reports of acute pancreatitis in patients taking Januvia – with 66 of these cases requiring hospitalization. Further, the researchers discovered that in more than half of the cases of Januvia acute pancreatitis, patients’ symptoms began to subside once they stopped taking Januvia.
A Januvia Lawsuit for Pancreatic Cancer victims claims that the manufacturers of Januvia either knew about Januvia’s pancreatic cancer risk, or should have known that the drug may lead to an increased risk of Pancreatic cancer. At this time there is currently no Januvia Class Action Lawsuit.
If you or a loved one has taken Januvia for the treatment of Type 2 diabetes and has subsequently developed pancreatic cancer, you are not alone. You may be entitled to financial compensation from the manufacturers through a Januvia Pancreatic Cancer Lawsuit against the makers of the potentially harmful drug. There is reason to believe that the manufacturer knew or should have known about these potential Januvia pancreatic cancer risks. Please call one of our pharmaceutical liability lawyers today for a free consultation regarding your Januvia Lawsuit. All Januvia lawsuits are processed on a contingency fee basis, which means that you don’t pay anything unless your case is successful. For more information about filing a pancreatic cancer lawsuit contact us at 1-800-883-9858 or use of contact form to the right ->